Zobrazeno 1 - 10
of 519
pro vyhledávání: '"Thomas J Polascik"'
Autor:
Elizabeth Noriega Landa, George E Quaye, Xiaogang Su, Sabur Badmos, Kiana L Holbrook, Thomas J Polascik, Eric S Adams, Sriram Deivasigamani, Qin Gao, Michael H Annabi, Ahsan Habib, Wen-Yee Lee
Publikováno v:
PLoS ONE, Vol 19, Iss 2, p e0297615 (2024)
The lack of accuracy in the current prostate specific antigen (PSA) test for prostate cancer (PCa) screening causes around 60-75% of unnecessary prostate biopsies. Therefore, alternative diagnostic methods that have better accuracy and can prevent ov
Externí odkaz:
https://doaj.org/article/7df10a3e5784499daeb41f0d51511fba
Autor:
Thomas J Polascik
Publikováno v:
Drug Design, Development and Therapy, Vol 2009, Iss default, Pp 27-40 (2008)
Thomas J PolascikDivision of Urology, Department of Surgery, Duke University Medical Center, Durham, NC, USAAbstract: Bone metastases frequently occur in patients with advanced solid tumors, particularly breast and prostate cancers, and nearly all pa
Externí odkaz:
https://doaj.org/article/5b7deecab6954c119870e0b26cf5cfbd
Autor:
Thomas J Polascik, Vladimir Mouraviev
Publikováno v:
Therapeutics and Clinical Risk Management, Vol 2008, Iss Issue 1, Pp 261-268 (2008)
Thomas J Polascik, Vladimir MouravievDuke Prostate Center and Division of Urologic Surgery, Duke University Medical Center, Durham, NC, USAAbstract: Many patients with advanced cancer experience decreased bone strength due to metastatic foci, underly
Externí odkaz:
https://doaj.org/article/51ad38244e3544a4bd3982e98d6ee349
Autor:
Yara Kadria-Vili, Jon A. Schwartz, Thomas J. Polascik, Glenn P. Goodrich, David Jorden, Diane Pinder, Naomi J. Halas, Ardeshir R. Rastinehad
Publikováno v:
Nanomaterials, Vol 14, Iss 15, p 1261 (2024)
AuroLase® Therapy—a nanoparticle-enabled focal therapy—has the potential to safely and effectively treat localized prostate cancer (PCa), preserving baseline functionality. This article presents a detailed case of localized PCa treated with Auro
Externí odkaz:
https://doaj.org/article/9ec6103815004d2789dcc3095b6c389a
Autor:
Maria Azrad, Kui Zhang, Robin T Vollmer, John Madden, Thomas J Polascik, Denise C Snyder, Mack T Ruffin, Judd W Moul, Dean Brenner, Robert W Hardy, Wendy Demark-Wahnefried
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e53104 (2012)
Previous observational studies have reported associations between prostate cancer and alpha-linolenic acid (ALA). However, few investigations have been able to study this relationship prospectively and in well-controlled settings. Moreover, no studie
Externí odkaz:
https://doaj.org/article/fdb2465e895943b5b751dee9b718457e
Publikováno v:
Urology. 175:144-150
Publikováno v:
Urology. 174:7-17
Autor:
Yu G. Tan, Yan M. Law, Nye T. Ngo, Li Y. Khor, Puay H. Tan, Enya H. W. Ong, John S. P. Yuen, Henry S. S. Ho, Jeffrey K. L. Tuan, Ravindran Kanesvaran, Rajan T. Gupta, Steven Rozen, Melvin L. K. Chua, Thomas J. Polascik, Kae Jack Tay
Publikováno v:
The Prostate. 83:781-791
Publikováno v:
Urologic Clinics of North America. 49:615-626
Despite newer therapies for castrate-resistant prostate cancer (CRPC), many patients do not experience a treatment response, and most eventually experience secondary resistance. Various androgen-receptor-related and alternative mechanisms of resistan
Autor:
Srinath Kotamarti, Rajan T. Gupta, Bangchen Wang, Denis Séguier, Zoe Michael, Dylan Zhang, Michael R. Abern, Jiaoti Huang, Thomas J. Polascik
Publikováno v:
European Urology Oncology. 5:483-493